Lessons from a community vaccination programme to control a meningococcal disease serogroup W outbreak in remote South Australia, 2017.
Adolescent
Adult
Community Health Services
Disease Outbreaks
/ prevention & control
Female
Humans
Immunization Programs
Male
Meningococcal Infections
/ epidemiology
Meningococcal Vaccines
/ administration & dosage
Middle Aged
Neisseria meningitidis
/ genetics
Program Evaluation
Serogroup
South Australia
/ epidemiology
Young Adult
Journal
Western Pacific surveillance and response journal : WPSAR
ISSN: 2094-7313
Titre abrégé: Western Pac Surveill Response J
Pays: Philippines
ID NLM: 101558993
Informations de publication
Date de publication:
Historique:
entrez:
7
6
2021
pubmed:
8
6
2021
medline:
4
8
2021
Statut:
epublish
Résumé
From December 2016 to February 2017, two cases of invasive meningococcal disease and one case of meningococcal conjunctivitis, all serogroup W, occurred in Aboriginal children in the Ceduna region of South Australia. The clustering of cases in time and place met the threshold for a community outbreak. The Ceduna region is a remote part of South Australia, with more than 25% of the population identifying as Aboriginal or Torres Strait Islander. As part of the outbreak response, a community-wide meningococcal vaccination programme against serogroups A, C, W and Y was implemented in a collaboration among different agencies of the South Australia Department for Health and Well-being, Aboriginal health and community services providers, and other local service providers and government agencies. The programme comprised an outbreak vaccination schedule, targeting all people aged Between March and June 2017, 3383 persons were vaccinated, achieving an estimated coverage of 71-85% of the target population, with 31% ( The participation of a large number of local and non-health-sector stakeholders in programme planning and implementation, a clear response management structure and high community acceptability were identified as key factors that contributed to the programme achieving high vaccination coverage. The need to develop standard operating procedures for community-based outbreak response interventions to ease logistical challenges was considered an important lesson learnt.
Identifiants
pubmed: 34094620
doi: 10.5365/wpsar.2019.10.2.002
pii: wpsar.2021.12.1-026
pmc: PMC8143929
doi:
Substances chimiques
Meningococcal Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
26-31Informations de copyright
(c) 2021 The authors; licensee World Health Organization.
Références
N Engl J Med. 2001 May 3;344(18):1378-88
pubmed: 11333996
Vaccine. 2019 May 9;37(21):2768-2782
pubmed: 30987851
BMJ Open. 2018 Jul 10;8(7):e020988
pubmed: 29991629
Euro Surveill. 2016;21(12):
pubmed: 27035055
Lancet Infect Dis. 2010 Dec;10(12):853-61
pubmed: 21075057
Vaccine. 2014 Apr 11;32(18):2042-9
pubmed: 24593997